As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

GLP-1 receptor agonists may aid smoking cessation by curbing cravings and mitigating weight gain, which often are impediments in quitting, according to a presentation at the American Psychiatric ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

“Our study found a similar incidence of obesity-related cancer among patients treated with first-generation glucagon-like peptide-1 receptor ... do not yet fully understand how GLP-1s work ...

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...

GLP-1 RAs are great medications to help with weight loss and are particularly effective in decreasing “food noise” and the ...